Development and validation of osteoporosis risk-assessment model for Korean postmenopausal women

被引:21
|
作者
Oh, Sun Min [1 ]
Nam, Byung-Ho [2 ]
Rhee, Yumie [3 ,4 ]
Moon, Seong-Hwan [5 ]
Kim, Deog Young [6 ]
Kang, Dae Ryong [7 ]
Kim, Hyeon Chang [1 ,8 ,9 ]
机构
[1] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul 120752, South Korea
[2] Natl Canc Ctr, Biometr Res Branch, Goyang 410769, Gyeonggi, South Korea
[3] Yonsei Univ, Coll Med, Endocrine Res Inst, Dept Internal Med, Seoul 120752, South Korea
[4] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 120752, South Korea
[5] Yonsei Univ, Coll Med, Dept Orthoped Surg, Seoul 120752, South Korea
[6] Yonsei Univ, Coll Med, Dept & Res Inst Rehabil Med, Seoul 120752, South Korea
[7] Yonsei Univ, Coll Med, Biostat Collaborat Unit, Seoul 120752, South Korea
[8] Yonsei Univ, Coll Med, Severance Inst Vasc & Metab Res, Seoul 120752, South Korea
[9] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA
关键词
Osteoporosis; Risk assessment; Postmenopausal women; Korea; FACILITATE IDENTIFICATION; ALKALINE-PHOSPHATASE; BONE TURNOVER; DENSITY; SELECTION; INDEX; TOOL; MANAGEMENT; OSTA;
D O I
10.1007/s00774-013-0426-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Currently, dual-energy X-ray absorptiometry (DXA) is the gold standard for detecting osteoporosis, but is not recommended for general population screening. Therefore, this study aims to develop an osteoporosis risk-assessment model to identify high-risk individuals among Korean postmenopausal women. Data from 1,209 and 1,046 postmenopausal women who participated in the 2009 and 2010 Korean National Health and Nutrition Examination Survey, respectively, were used for development and validation of an osteoporosis risk-assessment model. Osteoporosis was defined as T score less than or equal to -2.5 at either the femoral neck or lumbar spine. Performance of the candidate models and the Osteoporosis Self assessment Tool for Asians (OSTA) were compared with respect to sensitivity, specificity, and area under the receiver operating characteristics curve (AUC). To compare the developed Korean Osteoporosis Risk-Assessment Model (KORAM) with OSTA, a net reclassification improvement was further calculated. In the development dataset, the prevalence of osteoporosis was 33.9 %. KORAM, consisting of age, weight, and hormone therapy, had a sensitivity of 91.2 %, a specificity of 50.6 %, and an AUC of 0.709 with a specific cut-off score of -9. Comparable results were shown in the validation dataset: sensitivity 84.8 %, specificity 51.6 %, and AUC 0.682. Additionally, risk categorization with KORAM showed improved reclassification over that of OSTA from 7.4 to 41.7 %. KORAM can be easily used as a pre-screening tool to identify candidates for DXA tests. Further studies investigating cost-effectiveness and replicability in other datasets are required to establish the clinical utility of KORAM.
引用
收藏
页码:423 / 432
页数:10
相关论文
共 50 条
  • [1] Development and validation of osteoporosis risk-assessment model for Korean postmenopausal women
    Sun Min Oh
    Byung-Ho Nam
    Yumie Rhee
    Seong-Hwan Moon
    Deog Young Kim
    Dae Ryong Kang
    Hyeon Chang Kim
    [J]. Journal of Bone and Mineral Metabolism, 2013, 31 : 423 - 432
  • [2] Development and Validation of Osteoporosis Risk-Assessment Model for Korean Men
    Oh, Sun Min
    Song, Bo Mi
    Nam, Byung-Ho
    Rhee, Yumie
    Moon, Seong-Hwan
    Kim, Deog Young
    Kang, Dae Ryong
    Kim, Hyeon Chang
    [J]. YONSEI MEDICAL JOURNAL, 2016, 57 (01) : 187 - 196
  • [3] Development and validation of osteoporosis prescreening model for Iranian postmenopausal women
    Matin N.
    Tabatabaie O.
    Keshtkar A.
    Yazdani K.
    Asadi M.
    [J]. Journal of Diabetes & Metabolic Disorders, 14 (1):
  • [4] DEVELOPMENT AND VALIDATION OF A DISEASE MODEL FOR POSTMENOPAUSAL OSTEOPOROSIS
    Gauthier, A.
    Kanis, J. A.
    Martin, M.
    Compston, J.
    Borgstrom, F.
    Cooper, C.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A452 - A452
  • [5] Validation of the Gail model for breast cancer risk in postmenopausal women with osteoporosis.
    Goldstein, S.
    Yeo, A.
    Qu, Y.
    Wong, M.
    Mitchell, B.
    Mershon, J.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S175 - S176
  • [6] Development and validation of a disease model for postmenopausal osteoporosis
    Gauthier, A.
    Kanis, J. A.
    Martin, M.
    Compston, J.
    Borgstrom, F.
    Cooper, C.
    McCloskey, E.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 (03) : 771 - 780
  • [7] Development and validation of a disease model for postmenopausal osteoporosis
    A. Gauthier
    J. A. Kanis
    M. Martin
    J. Compston
    F. Borgström
    C. Cooper
    E. McCloskey
    [J]. Osteoporosis International, 2011, 22 : 771 - 780
  • [8] Prospective validation in 798 postmenopausal women of a new screening tool for osteoporosis risk assessment:: OSIRIS® (osteoporosis index of risk)
    Reginster, JY
    Viethel, P
    Micheletti, MC
    Chevallier, T
    Audran, M
    [J]. OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S37 - S38
  • [9] Prospective validation in 798 postmenopausal women of a new screening tool for osteoporosis risk assessment:: Osiris® (osteoporosis index of risk)
    Reginster, JY
    Viethel, P
    Micheletti, MC
    Chevallier, T
    Audran, M
    [J]. OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S94 - S94
  • [10] Assessment of Postmenopausal Women and Significant Risk Factors for Osteoporosis
    Schnatz, Peter F.
    Marakovits, Kimberly A.
    O'Sullivan, David M.
    [J]. OBSTETRICAL & GYNECOLOGICAL SURVEY, 2010, 65 (09) : 591 - 596